Alzheimer’s drug, the monoclonal antibody lecanemab, slowed decline in a phase 3 clinical trial, the company said.
Related Articles
-
Carolina Panthers guard Chandler Zavala taken to hospital after suffering a neck injury
DETROIT — Carolina Panthers guard Chandler Zavala was taken to a hospital after being carted off the field with a neck injury late...
-
Experimental gene therapy helps pancreatic cancer patient
An experimental treatment appears to have been successful in halting the progression of one woman’s advanced pancreatic cancer, doctors...
-
Screening for anxiety and depression useful for kids as young as 12, task force recommends
Routine screening for anxiety and depression may be useful for older children and teenagers, the U.S. Preventive Services Task...
-
After Covid, risks of heart problems remain elevated for up to a year
As far as Michelle Wilson knew, she’d recovered from Covid-19. Wilson, 65, contracted the virus in November 2020. Her...
-
FDA warns about lead contamination in more cinnamon products in the U.S.
The Food and Drug Administration issued a safety warning Wednesday, saying it identified additional cinnamon products in the United...
-
Some Jif peanut butter products are being recalled for possible salmonella contamination
WASHINGTON — Consumers should double-check their jars of Jif peanut butter amid a recall, the Food and Drug Administration and...
-
70-year-old woman in Uganda gives birth to twins after getting fertility treatments
KAMPALA, Uganda — A 70-year-old woman in Uganda has given birth to twins after receiving fertility treatment, making her...
-
Israel urges vaccination for all teens, citing delta variant
Israel on Monday recommended that all 12-15 year-olds be vaccinated against Covid-19, citing new outbreaks attributed to the more...
Recent Comments